Búsqueda avanzada

Arie S. Belldegrun es un emprendedor y empresario que fundó 6 empresas, entre ellas Kite Pharma, Inc., Allogene Therapeutics, Inc. y Agensys, Inc. y que ha estado al frente de 16 empresas diferentes. En la actualidad, ocupa el cargo de presidente y socio de Two River Group Holdings LLC, presidente de Two River Group Management LLC, presidente de Bellco Capital LLC (que fundó en 2003), presidente de Two Rivers Consulting Corp, presidente de UroGen Pharma Ltd., presidente y socio de Two River Consulting LLC, presidente ejecutivo de Allogene Therapeutics, Inc. (que fundó en 2017), presidente de Kronos Bio, Inc, copresidente de Breakthrough Properties LLC, director general sénior de VV Manager LLC (que fundó en 2017), director general sénior de Vida Ventures LLC (que fundó en 2017) (una filial de VV Manager LLC) y presidente de Technology Assessment Group. Arie S. Belldegrun también es director y profesor del Instituto de Oncología Urológica de la UCLA, jefe de la División de Oncología Urológica de la Facultad de Medicina David Geffen y director general sénior de Vida Ventures LLC (que fundó en 2017) y forma parte del consejo de administración de otras 5 empresas. El Dr. Belldegrun fue anteriormente presidente de Arno Therapeutics, Inc. y presidente no ejecutivo en Arno Therapeutics, Inc. (una filial de Arno Therapeutics, Inc.), presidente y director general de Equinor ASA, director de Agensys, Inc. (fundó la empresa en 1997), Presidente Ejecutivo, Presidente y Director General de Kite Pharma, Inc. (fundó la empresa en 2009), presidente del Comité de Tecnología Biológica Molecular de la American Urological Association Education & Research, Inc., investigador del Instituto Nacional del Cáncer y miembro del Comité de Economía y Empleo de Los Ángeles. Arie S. Belldegrun se doctoró en la Facultad de Medicina de la Universidad Hebrea Hadassah y se graduó en el Instituto de Ciencias Weizmann.

Ron Belldegrun is the founder and the Chief Executive Officer of ByHeart, Inc., a company founded in 2016.
He is also the founder and the Managing Partner of Consumer Health Ventures LLC, which is also founded in 2016.
Mr. Belldegrun previously worked as an Investor at Visium Asset Management LP.
He completed his undergraduate degree at the University of Pennsylvania in 2008.

Ben Belldegrun is the founder of Aliment Capital LLC, where he holds the title of Managing Partner starting in 2014.
He is also the founder of Lodestone BV.
Currently, Mr. Belldegrun holds director positions at Anuvia Plant Nutrients Corp., Concentric Ag Corp., Tropic Biosciences UK Ltd., Pairwise Plants Services, and Concentric Agriculture, Inc. Mr. Belldegrun's former position was as a Portfolio Manager at Brevan Howard Asset Management LLP from 2008 to 2011.
Mr. Belldegrun received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1998 and his MBA from the University of California, Los Angeles in 2004.

Rebecka Belldegrun is the founder of Bellco Capital LLC, where she holds the titles of President & Chief Executive Officer from 2003.
She is also the founder of Intertech Corp.
Dr. Belldegrun's current jobs include Director positions at BabyfirstTV, Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP, Trustee positions at California Institute of Technology and Museum Associates.
Dr. Belldegrun's former jobs include Director positions at First Media Corp.
and Independent Director position at Kronos Bio, Inc. Dr. Belldegrun received an undergraduate degree from Tel-Aviv University.

Dan Belldegrun founded Breakthrough Properties LLC, where he worked as Chief Executive Officer.